Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with appendix cancer at two high-volume centers https://t.co/IC54gNQyXU @ErikaBelmont7 @DavidSuMD @kturaga @jpshen_md @MikeWhiteMD @ArdamanShergil1
Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2024 – Jun 2024Where it's discussed
-
X / Twitter11 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions reflect a generally positive reception, with phrases like 'highlight the role' and 'prognostic and predictive biomarker' indicating appreciation of the research's clinical relevance. The tone is professional and forward-looking, emphasizing how ctDNA detection could significantly influence patient management strategies.
Most posts express approval and emphasize the significance of ctDNA as a useful biomarker in managing appendiceal cancers.
Discussions show moderate enthusiasm, highlighting the publication's role in advancing cancer monitoring techniques.
Participants reference clinical implications and the publication’s contribution to ongoing research, indicating thoughtful engagement.
The focus on improving prognosis and management suggests the findings could influence future clinical practices, implying a moderate to high impact.
Abstract in brief
- This study explores the use of circulating tumor DNA (ctDNA) in monitoring appendiceal cancers, finding it to be more sensitive than traditional markers and useful in predicting recurrence, especially after surgery.
- Patients who recently received systemic chemotherapy showed lower rates of ctDNA detection, suggesting therapy impacts ctDNA levels, which may influence monitoring strategies.
- Overall, ctDNA demonstrated high accuracy in detecting recurrence, making it a promising tool for managing and predicting outcomes in appendiceal cancer patients post-treatment.
Top posts
Most liked on X and BlueskyRT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
All mentions
Role of Circulating Tumor DNA in Managing Appendiceal Cancer
This study explores the use of circulating tumor DNA in monitoring appendiceal cancers, finding it to be more sensitive than traditional markers and useful in predicting recurrence, especially after surgery. ctDNA shows…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
RT @Varun_VBSurg: Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with ap…
Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with appendix cancer at two high-volume centers https://t.co/IC54gNQyXU @ErikaBelmont7 @DavidSuMD @kturaga @jpshen_md @MikeWhiteMD @ArdamanShergil1